Importance The coronavirus disease 2019 (COVID-19) pandemic prompted policy changes
to allow increased telehealth delivery of buprenorphine, a potentially lifesaving medication …

Importance Little is known about the potential implications of the rapid transition to telehealth
during the COVID-19 pandemic for treatment of opioid use disorder (OUD). Objective To …

Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …

Importance Early COVID-19 mitigation strategies placed an additional burden on individuals
seeking care for opioid use disorder (OUD). Telemedicine provided a way to initiate and …

Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

Importance Federal and state agencies granted temporary regulatory waivers to prevent
disruptions in access to medication for opioid use disorder (MOUD) during the COVID-19 …

Drawing upon a longitudinal survey of clinicians who treat patients with opioid use disorder
(OUD), we report changes over time in telemedicine use, clinicians' attitudes, and digital …

Background For patients receiving daily opioid agonist treatment (OAT) for opioid
dependence, several countries relaxed treatment guidelines at the beginning of the COVID …

Background During the pandemic, there was a dramatic shift to telemedicine for opioid use
disorder (OUD) treatment. Little is known about how clinician attitudes about telemedicine …